Suppliers / Eris Therapeutics

Eris Therapeutics

India Updated 9 July 2026

Eris Therapeutics is a finished-dose manufacturer based in India. It appears in 2 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by CDSCO (India), FDA (GH) and ANVISA (Brazil).

0
active US DMFs
0
valid CEPs
2
registered plants
2
filings across 1 regulators

Registered plants

Site FDA FEI
AHMEDABAD, India Not on file
ahmedabad 382 240, India Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) 2 2
FDA (GH) None 1
ANVISA (Brazil) None 1

Questions about Eris Therapeutics

Does Eris Therapeutics hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Eris Therapeutics. It does have 2 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Eris Therapeutics manufacture?
2 registered sites are on record, in India (Ahmedabad and Ahmedabad 382 240). Every site is listed on this page with the register it came from.
Which regulators recognise Eris Therapeutics's GMP?
Current GMP certificates are on record from CDSCO (India), FDA (GH) and ANVISA (Brazil). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Eris Therapeutics comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates